Signal Peptide Website
Search my Protein
Advanced Search
Database Search
References
Hints
Links
Imprint
Signal Peptide Database - Drosophila melanogaster
Entry Details
ID
5333
Source Database
UniProtKB/Swiss-Prot
UniProtKB/Swiss-Prot Accession Number
P34082 (Created: 1994-02-01 Updated: 2009-01-20)
UniProtKB/Swiss-Prot Entry Name
FAS2_DROME
Protein Name
Fasciclin-2
Gene
Fas2
Organism Scientific
Drosophila melanogaster
Organism Common
Fruit fly
Lineage
Eukaryota
Metazoa
Arthropoda
Hexapoda
Insecta
Pterygota
Neoptera
Endopterygota
Diptera
Brachycera
Muscomorpha
Ephydroidea
Drosophilidae
Drosophila
Sophophora
Protein Length [aa]
873
Protein Mass [Da]
96926
Features
Type
Description
Status
Start
End
signal peptide
potential
1
28
chain
Fasciclin-2
29
873
disulfide bond
potential
54
116
disulfide bond
potential
159
207
disulfide bond
potential
251
302
disulfide bond
potential
343
407
disulfide bond
potential
451
504
transmembrane region
potential
752
769
topological domain
Extracellular
potential
29
751
topological domain
Cytoplasmic
potential
770
873
domain
Ig-like C2-type 1
31
131
domain
Ig-like C2-type 2
138
223
domain
Ig-like C2-type 3
230
318
domain
Ig-like C2-type 4
323
423
domain
Ig-like C2-type 5
428
520
domain
Fibronectin type-III 1
525
619
domain
Fibronectin type-III 2
630
734
modified residue
Phosphoserine
827
827
modified residue
Phosphothreonine
841
841
modified residue
Phosphoserine
845
845
glycosylation site
N-linked (GlcNAc...)
potential
74
74
glycosylation site
N-linked (GlcNAc...)
potential
250
250
glycosylation site
N-linked (GlcNAc...)
330
330
glycosylation site
N-linked (GlcNAc...)
potential
448
448
glycosylation site
N-linked (GlcNAc...)
potential
458
458
glycosylation site
N-linked (GlcNAc...)
576
576
splice variant
(in isoform 3)
0
0
splice variant
(in isoform 2)
0
0
splice variant
(in isoform 3)
774
873
splice variant
(in isoform 2)
812
873
SP Length
28
----+----1----+----2----+----3----+----4----+----5
Signal Peptide
MGELPPNSVGVFLALLLCSCSLIELTRA
Sequence
MGELPPNSVGVFLALLLCSCSLIELTRA
QS
PILEIYPKQEVQRKPVGKPL
ILTCRPTVPEPSLVADLQWKDNR
N
NTILPKPNGRNQPPMYTETLPGESLA
LMITSLSVEMGGKYYCTASYANTEILEKGVT
IKTYVA
ITWTNAPENQYPT
LGQDYVVMCEVKADPNPTIDWLRNGDPIRTTNDKYVVQTNGLLIRNVQES
DEGIYTCRAAVIETGELLERTIR
VEVFIQ
PEIISLPTNLEAVEGKPFAA
N
CTARGKPVPEISWIRDATQLNVATADRFQVNPQTGLVTISSVSQDDYGTY
TCLAKNRAGVVDQKTKLN
VLVR
PQIYELY
N
VTGARTKEIAITCRAKGRPA
PAITFRRWGTQEEYTNGQQDDDPRIILEPNFDEERGESTGTLRISNAERS
DDGLYQCIARNKGADAYKTGHIT
VEFA
PDFSHMKELPPVFSWEQRKA
N
LS
CLAMGIP
N
ATIEWHWNGRKIKDLYDTNLKIVGTGPRSDLIVHPVTRQYYS
GYKCIATNIHGTAEHDMQLK
EARV
PDFVSEAKPSQLTATTMTFDIRGPST
ELGLPILAYSVQYKEALNPDWSTAY
N
RSWSPDSPYIVEGLRPQTEYSFRF
AARNQVGLGNWGVNQQQST
PRRSAPEEPK
PLHNPVQHDKEEPVVVSPYSD
HFELRWGVPADNGEPIDRYQIKYCPGVKISGTWTELENSCNTVEVMETTS
FEMTQLVGNTYYRIELKAHNAIGYSSPASIIMKT
TRGIDVIQVAERQVFS
S
AAIVGIAIGGVLLLLFVV
DLLC
CITVHMGVMATMCRKAKRSPSEIDDEA
KLGSGQLVKEP
PPSPLPLPPPVKLGGSPMSTPLDEKEPLRTPTGSIKQNS
TIEFDGRFVHSRSGEIIGKNSAV
Original
MGELPPNSVGVFLALLLCSCSLIELTRAQSPILEIYPKQEVQRKPVGKPL
ILTCRPTVPEPSLVADLQWKDNRNNTILPKPNGRNQPPMYTETLPGESLA
LMITSLSVEMGGKYYCTASYANTEILEKGVTIKTYVAITWTNAPENQYPT
LGQDYVVMCEVKADPNPTIDWLRNGDPIRTTNDKYVVQTNGLLIRNVQES
DEGIYTCRAAVIETGELLERTIRVEVFIQPEIISLPTNLEAVEGKPFAAN
CTARGKPVPEISWIRDATQLNVATADRFQVNPQTGLVTISSVSQDDYGTY
TCLAKNRAGVVDQKTKLNVLVRPQIYELYNVTGARTKEIAITCRAKGRPA
PAITFRRWGTQEEYTNGQQDDDPRIILEPNFDEERGESTGTLRISNAERS
DDGLYQCIARNKGADAYKTGHITVEFAPDFSHMKELPPVFSWEQRKANLS
CLAMGIPNATIEWHWNGRKIKDLYDTNLKIVGTGPRSDLIVHPVTRQYYS
GYKCIATNIHGTAEHDMQLKEARVPDFVSEAKPSQLTATTMTFDIRGPST
ELGLPILAYSVQYKEALNPDWSTAYNRSWSPDSPYIVEGLRPQTEYSFRF
AARNQVGLGNWGVNQQQSTPRRSAPEEPKPLHNPVQHDKEEPVVVSPYSD
HFELRWGVPADNGEPIDRYQIKYCPGVKISGTWTELENSCNTVEVMETTS
FEMTQLVGNTYYRIELKAHNAIGYSSPASIIMKTTRGIDVIQVAERQVFS
SAAIVGIAIGGVLLLLFVVDLLCCITVHMGVMATMCRKAKRSPSEIDDEA
KLGSGQLVKEPPPSPLPLPPPVKLGGSPMSTPLDEKEPLRTPTGSIKQNS
TIEFDGRFVHSRSGEIIGKNSAV
----+----1----+----2----+----3----+----4----+----5
Hydropathies
Home
Imprint
© 2007-2017
Dr. Katja Kapp
, Kassel &
thpr.net e. K.
, Dresden, Germany, last update 2010-06-11